Ash Stevens Spring Show Guide
Ash Stevens Inc., a full service contract pharmaceutical manufacturer (CMO), has been providing small-molecule drug substance development and cGMP manufacturing services to Life Science companies for over fifty years. The company recently completed construction of a large-scale reactor bay housing 2000, 3000, and 4000 liter glass-lined reactors and an accompanying large-scale isolation bay equipped with a 1.5-m2 filter dryer with glovebox technology at its state-of-art manufacturing facility located in Riverview, Michigan.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
